Top-level executive changes at GSK in Japan
This article was originally published in Scrip
Philippe Fauchet had been appointed president of GlaxoSmithKline in Japan, effective immediately. He succeeds Marc Dunoyer, who becomes chairman of the subsidiary. Mr Fauchet is a former president of Sanofi-Aventis in Japan, a post from which he stepped down in 2008. He was most recently a senior vice-president for business development at Sanofi-Aventis in France.